|
|
| Research article summary (published Mar 2008): |
Immunological methods to quantify and characterize proteasome complexes: development and application.
Full Abstract
The ubiquitin-proteasome pathway plays major roles in all aspects of biology and contributes to various disease processes. Due to the lack of assays that permit proteasome quantification in crude cell extracts, its concentrations in health and disease states as well as the relationship between free 20S core particles (20S) and 26S proteasomes (26S) that consist of 20S singly or doubly capped with 19S regulator complexes (19S) are still largely unknown. Thus, we established a 20S ELISA for the detection of total 20S, and developed a specific 26S ELISA. The latter utilizes the ATP/Mg2+ requirement for 26S stability and shows no cross-reactivity with 20S. Both ELISAs demonstrate intra- and inter-assay variations between 4.9% and 9.4% and recoveries of 105%-109%. Initial application showed that maintenance of the physiological ATP concentration is essential for accurate 26S assessment. Measurements in erythrocyte and peripheral blood mononuclear cell (PBMNC) extracts revealed that the concentrations of 20S were 15-fold and of 26S 130-fold higher in PBMNCs, and suggested that the 26S is the physiological relevant form in PBMNCs (molar ratio 20S/26S 1.1+/-0.4), whereas free 20S is predominant in erythrocytes (molar ratio 20S/26S: 11.5+/-4.0). During storage of packed red blood cell units spontaneous 26S assembly was detectable while specific 26S enzyme activities decreased, indicating that these assays are useful to assess the dynamic interplay between the 20S and 19S. During 26S assay development we further observed that solid phase affinity immobilization (SPAI) of 26S enables quantification of its dissociation into 20S and 19S. Utilizing the SPAI-26S method in combination with the non-hydrolyzable analogue ATP[beta,gamma-NH] and Mg2+ depletion, we provided evidence that ATP binding without hydrolysis via a high affinity binding site (Kd 4-6 microM) as well as ATP binding with hydrolysis via a low affinity binding site that is virtually not saturable under physiological conditions is required to fully stabilize the 26S. Application of these immunological techniques is expected to facilitate proteasome analyses, and may help to better understand its roles in health and disease processes.
Author information
Author/s: Majetschak, Matthias (M); Sorell, Luis T (LT);
Affiliation: DeWitt Daughtry Family Department of Surgery, Division of Trauma and Surgical Critical Care-Trauma Research, University of Miami Miller School of Medicine, Miami, FL 33136, USA. mmajetschak(-atsign-)med.miami.edu
Journal and publication information
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.
Journal: Journal of immunological methods (J Immunol Methods), published in Netherlands. (Language: eng)
Reference: 2008-May; vol 334 (issue 1-2) : pp 91-103
Dates: Created 2008/04/21; Completed 2008/07/08;
PMID: 18343400, status: MEDLINE (last retrieval date: 2/18/2009, IMS Date: )
Sourced from the National Library of Medicine. Abstract text and other information may be subject to copyright.
External Links for this article
(including full text providers, if available):
Click Electronic Full-text Provider Links to see options for finding the electronic full text links to this article. Note there may be a subscription or fee required for access to the full text. See our FAQ for information on finding FREE full text articles.
This article may also be located in paper journal collections available in many libraries. Use the Journal and Publication Information above to find the full article.
MeSH headings (categories)
This article was linked to the MESH Headings shown below.
Related articles
These are the highest related articles currently in the database:
- Simplified methods for isolation of ubiquitin from erythrocytes. Generation of ubiquitin polymers.
30 Dec 1986 - Ubiquitin with a non-ATP-dependent slow intrinsic proteolytic activity: a mild and rapid purification procedure.
30 May 1992 - Circulating 20S proteasome levels in patients with mixed connective tissue disease and systemic lupus erythematosus.
28 Jul 2008 - Serum concentrations of free ubiquitin and multiubiquitin chains.
29 Jun 1997 - Proteasome subunits are regulated and expressed in comparable concentrations as a functional cluster.
4 Dec 2008 - Purification of PA700, the 19S regulatory complex of the 26S proteasome.
30 Dec 2004 - Bortezomib and gemcitabine in relapsed or refractory Hodgkin's lymphoma.
23 May 2008 - Multiple forms of ubiquitin-protein ligase. Binding of activated ubiquitin to protein substrates.
Jun 1986 - Synthesis and characterization of ubiquitin ethyl ester, a new substrate for ubiquitin carboxyl-terminal hydrolase.
19 Oct 1986 - Antihistone antibodies in systemic lupus erythematosus: assay dependency and effects of ubiquitination and serum DNA.
30 May 1994
Related Article Map
Legend:
- FREE Full text Article.
- Abstract only.
- Title only. More help.
See a large map of 100+ related articles.